NEW YORK, NY, Precision Neuroscience, a brain-computer interface company, announced a $41 million Series B funding round led by Forepont Capital Partners.
Precision Neuroscience Corporation, a brain-computer interface (BCI) company developing implants that are designed to be high-resolution, minimally invasive, and reversible, announced a $41 million Series B funding round led by Forepont Capital Partners. Mubadala Capital, Draper Associates, Alumni Ventures, and re.Mind Capital also participated in the round, alongside existing investors Steadview Capital and B Capital Group.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
